Giuffrida A - Search Results

1

The endocannabinoid system during development: emphasis on perinatal events and delayed effects.

Fride E, Gobshtis N, Dahan H, Weller A, Giuffrida A, Ben-Shabat S. Fride E, et al. Among authors: giuffrida a. Vitam Horm. 2009;81:139-58. doi: 10.1016/S0083-6729(09)81006-6. Vitam Horm. 2009. PMID: 19647111 Review.

2

The endocannabinoid system: a physiological perspective on its role in psychomotor control.

Giuffrida A, Piomelli D. Giuffrida A, et al. Chem Phys Lipids. 2000 Nov;108(1-2):151-8. doi: 10.1016/s0009-3084(00)00193-6. Chem Phys Lipids. 2000. PMID: 11106788 Review.

3

The endocannabinoid system as a target for therapeutic drugs.

Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F. Piomelli D, et al. Among authors: giuffrida a. Trends Pharmacol Sci. 2000 Jun;21(6):218-24. doi: 10.1016/s0165-6147(00)01482-6. Trends Pharmacol Sci. 2000. PMID: 10838609 Free article. Review.

4

Evidence that anandamide-signaling regulates human sperm functions required for fertilization.

Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A. Schuel H, et al. Among authors: giuffrida a. Mol Reprod Dev. 2002 Nov;63(3):376-87. doi: 10.1002/mrd.90021. Mol Reprod Dev. 2002. PMID: 12237954

5

Exercise activates the endocannabinoid system.

Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Sparling PB, et al. Among authors: giuffrida a. Neuroreport. 2003 Dec 2;14(17):2209-11. doi: 10.1097/00001756-200312020-00015. Neuroreport. 2003. PMID: 14625449

6

In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

Giuffrida A, McMahon LR. Giuffrida A, et al. Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):90-103. doi: 10.1016/j.prostaglandins.2009.05.004. Epub 2009 Jun 10. Prostaglandins Other Lipid Mediat. 2010. PMID: 19523530 Free PMC article. Review.

7

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.

Giuffrida A, Parsons LH, Kerr TM, Rodríguez de Fonseca F, Navarro M, Piomelli D. Giuffrida A, et al. Nat Neurosci. 1999 Apr;2(4):358-63. doi: 10.1038/7268. Nat Neurosci. 1999. PMID: 10204543

8

Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.

Giuffrida A, Beltramo M, Piomelli D. Giuffrida A, et al. J Pharmacol Exp Ther. 2001 Jul;298(1):7-14. J Pharmacol Exp Ther. 2001. PMID: 11408519 Review.

9

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms.

Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkötter J, Piomelli D. Giuffrida A, et al. Neuropsychopharmacology. 2004 Nov;29(11):2108-14. doi: 10.1038/sj.npp.1300558. Neuropsychopharmacology. 2004. PMID: 15354183

10

A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena.

Solbrig MV, Adrian R, Baratta J, Piomelli D, Giuffrida A. Solbrig MV, et al. Among authors: giuffrida a. Exp Neurol. 2005 Aug;194(2):355-62. doi: 10.1016/j.expneurol.2005.02.017. Exp Neurol. 2005. PMID: 16022863 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page